News Room

   Since ProVac's beginning in September 2006, the program has been actively conducting analysis, workshops, and field studies in the Region.

ProVac in PAHO's Immunization Newsletter

• Multiyear project proposal for the promotion of evidence-based policy decisions for new vaccine introduction in Latin America and the Caribbean

• Descriptive analysis of immunization policy decision-making in the Americas
  ProVac: Cost-effectiveness Analysis of Rotavirus Vaccines

• Network of ProVac Centers of Excellence in Economic Evaluations and Decision Analysis

• On-line International Vaccine Economics and Statistics (OLIVES)

• ProVac Model for Evaluating the Costeffectiveness of Cervical Cancer Control Strategies

ProVac in WHO's Global Immunization Newsletter

• Report of the ProVac HPV Costing Workshop

• ProVac Workshop on the Essential Components of a Cost-effectiveness Analysis: the case of the rotavirus vaccine

• Report of the Meeting of the Network of ProVac Centers of Excellence in Economic Evaluations and Decision Analysis

• ProVac Workshop to Finalize Country-led Cost-effectiveness Analyses on Rotavirus and Pneumococcal Conjugate Vaccines in 7 Countries

• Meeting of Centers of Excellence in Economic Evaluations and Decision Analysis – ProVac Initiative

• The ProVac Initiative Pilot tests HPV decision support tool in Jamaica

• ProVac Model for Evaluating the Cost-effectiveness of Cervical Cancer Control Strategies

• Fourth ProVac Network of Centers of Excellence Meeting

• ProVac Visit to Peru and El Salvador: A Launch and a Closing of a Pneumococcal Conjugated Vaccine (PCV) Cost-effectiveness Analysis

• ProVac Experience-Sharing Workshop: Cost-effectiveness analyses of cervical cancer prevention and control strategies

• The ProVac International Working Group begins its first Country Study of the Two-year Pilot Phase